Carmel, IN, United States of America

Thibault Francois Varin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thibault Francois Varin. Retrieved from https://idiyas.com/inventor/thibault-francois-varin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thibault Francois Varin: Innovator in cGAS Inhibitors

Introduction

Thibault Francois Varin is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cGAS inhibitors. His work focuses on innovative compounds that have the potential to treat various immune-mediated diseases.

Latest Patents

Thibault holds 1 patent related to cGAS inhibitors. The present invention pertains to novel cGAS inhibitor compounds, which are designed to provide pharmaceutical compositions for treating specific pathological conditions. These compounds are crucial in addressing immune-mediated diseases, showcasing the potential impact of his research.

Career Highlights

Thibault is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves extensive research and development, contributing to the advancement of therapeutic solutions in the medical field.

Collaborations

Thibault collaborates with esteemed colleagues, including Francisco Javier Agejas Chicharro and Shanthi Nagarajan. Their combined expertise enhances the innovative efforts within their projects, fostering a collaborative environment that drives scientific discovery.

Conclusion

Thibault Francois Varin exemplifies the spirit of innovation in the pharmaceutical industry through his work on cGAS inhibitors. His contributions not only advance scientific knowledge but also hold promise for improving patient outcomes in immune-mediated diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…